login / register

Johnson & Johnson to buy Abiomed Inc for $16.6 billion

Johnson & Johnson is splashing out $16.6 billion for Abiomed Inc, a medical technology company.

The American healtchare giant is making an upfront payment of $380 in cash and is also offering $35.00 per share in cash if certain commercial and clinical milestones are achieved.

That's a premium of over 50pc for Abiomed Inc!

Below is a link the press release:..

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Tuesday, 1 November 2022, 11:33 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation